登录 注册 会员服务 联系我们

Response assessment in Waldenström macroglobulinaemia: update from the VIth International Workshop

  • Published:2012-11-15 Issue:2 Volume:160 Page:171-176
  • ISSN:0007-1048
  • Container-title:British Journal of Haematology
  • language:en
  • Short-container-title:Br J Haematol

Author:

Owen Roger G.1,Kyle Robert A.2,Stone Marvin J.3,Rawstron Andy C.1,Leblond Veronique4,Merlini Giampaolo5,Garcia-Sanz Ramon6,Ocio Enrique M.6,Morra Enrica7,Morel Pierre8,Anderson Kenneth C.9,Patterson Christopher J.9,Munshi Nikhil C.9,Tedeschi Alessandra7,Joshua Douglas E.10,Kastritis Efstathios11,Terpos Evangelos11,Ghobrial Irene M.9,Leleu Xavier12,Gertz Morie A.2,Ansell Stephen M.2,Morice William G.2,Kimby Eva13,Treon Steven P.9

Affiliation:

1. St James's University Hospital; Leeds; UK

2. Mayo School of Medicine; Rochester; MN; USA

3. Baylor Sammons Cancer Center; Dallas; TX; USA

4. Hopital Pitie Salpetriere; Paris; France

5. IRCCS Policlinico San Matteo and University of Pavia; Pavia; Italy

6. Hospital Universitario de Salamanca; Salamanca; Spain

7. Niguarda Ca'Granda Hospital; Milan; Italy

8. Hospitalier Schaffner; Lens; France

9. Dana Farber Cancer Institute; Harvard Medical School; Boston; MA; USA

10. Royal Prince Alfred Hospital; Sydney; NSW; Australia

11. University of Athens School of Medicine; Athens; Greece

12. Hopital Huriez; Lille; France

13. Karolinska Institute and Karolinska University Hospital; Stockholm; Sweden

Publisher

Wiley

Subject

Hematology

Reference35 articles.

1. The role of 18F-FDG PET/CT imaging in Waldenstrom macroglobulinemia;Banwait;American Journal of Hematology,2011

2. Residual monotypic plasma cells in patients with Waldenstrom macroglobulinemia after therapy;Barakat;American Journal of Clinical Pathology,2011

3. Bortezomib is active in patients with untreated or relapsed Waldenstrom's macroglobulinemia: a phase II study of the National Cancer Institute of Canada Clinical Trials Group;Chen;Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology,2007

4. Delayed response to fludarabine in lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia;Del Giudice;Haematologica,2005

5. Post-treatment bone marrow residual disease >5% by flow cytometry is highly predictive of short progression-free and overall survival in patients with Waldenström's macroglobulinemia;García-Sanz;Clinical Lymphoma, Myeloma & Leukemia,2011
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3